A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- Status
- RECRUITING
- Phase
- PHASE1
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients
- Status
- TERMINATED
- Phase
- PHASE2
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE3